{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidcffjbtlwt42f67imkuwd3bm7t7ey7usqwzrxbzjzh5kfgqjpqiq",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjppkais7ek2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibmvr2im23trj5s2ygpx3xynpv5w7fl42why3smvagozgjbgftdhe"
    },
    "mimeType": "image/jpeg",
    "size": 650121
  },
  "path": "/news/2026-04-weight-loss-notable-muscle.html",
  "publishedAt": "2026-04-17T14:40:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for type 2 diabetes and obesity, finds they are associated with high rates of muscle loss relative to the amount of weight lost.",
  "title": "Weight loss leads to notable muscle loss, study finds"
}